Version history
1 version on record. Newest first; the live version sits at the top with a live indicator.
- Live4/28/2026, 1:22:44 AM
Content snapshot
{ "session_id": "sess_0ed3c364-07fd-4620-8e90-8bd33c14e370_task_66f1207e_recon", "round_number": 4, "agent_persona": "persona-synthesizer", "agent_backend": "scidex.core.llm.complete", "action": "synthesize", "content": "{\n \"ranked_hypotheses\": [\n {\n \"title\": \"RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation as proximal driver in Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons\",\n \"description\": \"RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a measurable proximal phenotype before late disease pathology. The decisive test is time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography.\",\n \"target_gene\": \"TDP-43\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.62,\n \"novelty\": 0.72,\n \"feasibility\": 0.67,\n \"therapeutic_potential\": 0.64,\n \"mechanistic_plausibility\": 0.7,\n \"druggability\": 0.54,\n \"safety_profile\": 0.52,\n \"competitive_landscape\": 0.58,\n \"data_availability\": 0.66,\n \"reproducibility\": 0.61\n },\n \"composite_score\": 0.626,\n \"evidence_for\": [\n {\n \"claim\": \"Mechanistic review of FUS/TDP-43 phase separation highlighted that the temporal ordering of nuclear loss-of-function versus cytoplasmic gain-of-function remains unresolved and therapeutically critical.\",\n \"doi\": \"10.14336/ad.2023.1118\",\n \"source\": \"Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43\"\n }\n ],\n \"evidence_against\": [\n {\n \"claim\": \"in-vitro condensate rules may not transfer cleanly to crowded, stressed patient neurons\",\n \"doi\": \"10.14336/ad.2023.1118\",\n \"source\": \"Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43\"\n }\n ]\n },\n {\n \"title\": \"Cell-state stratification is required to resolve Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons\",\n \"description\": \"The question is likely underpowered or misleading unless analyses preserve the key strata: TDP-43, ALS. Averaging across these strata could convert a causal subpopulation effect into a weak association.\",\n \"target_gene\": \"ALS\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.58,\n \"novelty\": 0.64,\n \"feasibility\": 0.73,\n \"therapeutic_potential\": 0.55,\n \"mechanistic_plausibility\": 0.65,\n \"druggability\": 0.45,\n \"safety_profile\": 0.62,\n \"competitive_landscape\": 0.56,\n \"data_availability\": 0.7,\n \"reproducibility\": 0.64\n },\n \"composite_score\": 0.612,\n \"evidence_for\": [\n {\n \"claim\": \"The open question explicitly depends on cell-type, region, or molecular-state resolution.\",\n \"doi\": \"10.14336/ad.2023.1118\"\n }\n ],\n \"evidence_against\": [\n {\n \"claim\": \"Stratified effects may reflect sampling or annotation artifacts rather than mechanism.\",\n \"doi\": \"10.14336/ad.2023.1118\"\n }\n ]\n },\n {\n \"title\": \"Perturbation-first validation should precede therapeutic claims for Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons\",\n \"description\": \"The debate supports treating this as a validation program before ranking it as a therapy. Perturbation should move a proximal molecular phenotype, then a disease-relevant phenotype, in that order.\",\n \"target_gene\": \"\",\n \"dimension_scores\": {\n \"evidence_strength\": 0.55,\n \"novelty\": 0.6,\n \"feasibility\": 0.76,\n \"therapeutic_potential\": 0.57,\n \"mechanistic_plausibility\": 0.63,\n \"druggability\": 0.48,\n \"safety_profile\": 0.6,\n \"competitive_landscape\": 0.55,\n \"data_availability\": 0.68,\n \"reproducibility\": 0.66\n },\n \"composite_score\": 0.608,\n \"evidence_for\": [\n {\n \"claim\": \"The proposed priority experiment is concrete: time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography\",\n \"doi\": \"10.14336/ad.2023.1118\"\n }\n ],\n \"evidence_against\": [\n {\n \"claim\": \"Therapeutic tractability is not established by the current source evidence.\",\n \"doi\": \"10.14336/ad.2023.1118\"\n }\n ]\n }\n ],\n \"knowledge_edges\": [\n {\n \"source_id\": \"0ed3c364-07fd-4620-8e90-8bd33c14e370\",\n \"source_type\": \"analysis\",\n \"target_id\": \"TDP-43\",\n \"target_type\": \"entity\",\n \"relation\": \"debate_reconstructs_evidence_for\"\n },\n {\n \"source_id\": \"0ed3c364-07fd-4620-8e90-8bd33c14e370\",\n \"source_type\": \"analysis\",\n \"target_id\": \"ALS\",\n \"target_type\": \"entity\",\n \"relation\": \"debate_reconstructs_evidence_for\"\n }\n ],\n \"synthesis_summary\": \"Consensus: Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons is a valid debate target because it is anchored to Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43 and asks a falsifiable question about RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation. Dissent: the source evidence does not yet prove causality, and in-vitro condensate rules may not transfer cleanly to crowded, stressed patient neurons. The next step is time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography.\"\n}", "tokens_used": "1406", "persona_id": "persona-synthesizer" }